An emerging treatment tool which uses replication-competent viruses to dissipate cancers
without causing deficit to normal tissues, named as oncolytic virotherapy, is discussed in the …

A fractional-order tumor virotherapy model with two time delays is presented and analyzed
in this paper. The existence, positivity and bounbdedness of solutions under positive initial …

In this paper, we investigate how natural killer (NK) cell recruitment to the tumor
microenvironment (TME) affects oncolytic virotherapy. NK cells play a major role against …

We investigate a mathematical model of tumor–immune system interactions with oncolytic
virus therapy (OVT). Susceptible tumor cells may become infected by viruses that are …

The provision of additional food (AF) sources to an introduced predator has been identified
as a mechanism to improve pest control. However, AF models with prey dependent …

A non-local delay differential system was developed by age-infected consideration to
understand the interaction between tumor cells and oncolytic virus. The critical threshold …

We revisit and carry out further computations on tumor-virotherapy compartmental models of
Tian (Math Biosci Eng 8 (3): 841,), Wang et al.(Appl Math Model 37 (8): 5962–5978,), Phan …

Oncolytic viruses (OVs) exploit characteristics of mass cells and tumor-related reaction of the
body to the presence of antigen, to lyse malignant cells and modulate the tumor …

Oncolytic virotherapy is emerging as a promising new method for cancer treatment. In this
paper, we consider a mathematical model for treatment of cancer by using oncolytic …

The action of a tumor on the immune system includes stimulation and neutralization, which
usually have different time delays. In this work we propose a tumor-immune system to …